GIRGIS, I.; CHIMALAKONDA, A.; JONES III, J.; DOCKENS, R.; MARCHISIN, D.; DARBENZIO, R.; SINGHAL, S.; THROUP, J.; BANERJEE, S. Lack of ECG effects of BMS-986165, an oral, selective tyrosine kinase 2 (TYK2) inhibitor: results from a thorough QT study in healthy subjects. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, p. S13, 2019. DOI: 10.25251/skin.3.supp.13. Disponível em: https://jofskin.org/index.php/skin/article/view/740. Acesso em: 23 jul. 2024.